Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RREGENERON PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

REGENERON PHARMACEUTICALS, INC.

$787.20Close · Sep 25, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement income statement flow. Revenue $4.29B. Net result $1.3B.

Income statement revenue $4.29B (+16.7% YoY).Operating income $1.29B (+19.8% YoY).Pre-tax result $1.53B (+0.6% YoY).Net result $1.3B (-6.8% YoY).

  • Operating costs: $3B (+15.5% YoY)
  • Other income: $234.3M (-46.7% YoY)
  • Income tax expense: $230.9M (+81.7% YoY)